Ethanol is one of 95 small molecule programs targeting Imaging. It is currently in Phase 3.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
34 competitors in Imaging
Nicorette
Ritalin
Ethanol
Obicetrapib
F-Arag
Hyperpolarized 13c Pyruvate
PET Scan With VAT
XTR006
Ga-FAPI-46
Methylreboxetine
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources